| Titolo |
Pubblicato in |
Anno |
| A role for ceftazidime/avibactam combination therapy. The question may still be on the table |
INFECTION |
2024 |
| Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience |
FRONTIERS IN MICROBIOLOGY |
2024 |
| Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin |
JAC-ANTIMICROBIAL RESISTANCE |
2024 |
| Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing K. pneumoniae bloodstream infection: a retrospective cohort study |
JAC-ANTIMICROBIAL RESISTANCE |
2024 |
| Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study |
OPEN FORUM INFECTIOUS DISEASES |
2023 |
| Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin |
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY |
2023 |
| Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations |
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE |
2023 |
| New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis? |
LE INFEZIONI IN MEDICINA |
2023 |
| An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants |
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |
2022 |
| Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study |
INFECTION |
2022 |
| Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV |
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |
2022 |
| Risk of Seven-Day Worsening and Death: A New Clinically Derived COVID-19 Score |
VIRUSES |
2022 |
| Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study |
JAC-ANTIMICROBIAL RESISTANCE |
2022 |
| Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study |
INFECTION |
2022 |
| Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w) |
INFECTION |
2022 |
| Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside |
ANTIBIOTICS |
2021 |
| The role of combination therapy in critically Ill patients with methicillin-susceptible staphylococcus aureus bloodstream infections. Does the question remain? |
CLINICAL INFECTIOUS DISEASES |
2021 |
| Place in Therapy of the Newly Available Armamentarium for Multi-Drug-Resistant Gram-Negative Pathogens: Proposal of a Prescription Algorithm |
ANTIBIOTICS |
2021 |
